You just read:

CytRx to Present Data at the European Society for Medical Oncology 2016 Congress from Aldoxorubicin Plus Ifosfamide/Mesna Combination Clinical Trial

News provided by

CytRx Corporation

12 Sep, 2016, 09:00 ET